Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis

被引：2
|
作者：
Ardizzoia, Federica [1 ,2 ,4 ]
Lorentino, Francesca [1 ,2 ,3 ]
Bruno, Alessandro [1 ]
Marktel, Sarah [1 ]
Giglio, Fabio [1 ]
Clerici, Daniela [1 ]
Farina, Francesca [1 ]
Mastaglio, Sara [1 ]
Piemontese, Simona [1 ]
Assanelli, Andrea A. [1 ]
Carrabba, Matteo G. [1 ]
Bernardi, Massimo [1 ]
Corti, Consuelo [1 ]
Peccatori, Jacopo [1 ]
Ciceri, Fabio [1 ,2 ]
Greco, Raffaella [1 ]
Lupo-Stanghellini, Maria Teresa [1 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Univ Milano Bicocca, Dept Med & Surg, PhD Program Publ Hlth, Milan, Italy
[4] Univ Bologna, IRCCS Azienda Osped Univ Bologna Policlin St Orso, Ist Ematol & Oncol Medica LeA Seragnoli, Alma Mater Studiorum, Bologna, Italy
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 11期
关键词：
ACUTE GVHD;
D O I：
10.3324/haematol.2022.281269
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2748 / 2751
页数：4
相关论文
共 50 条
  • [21] Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease
    Kumar, S
    Chen, MG
    Gastineau, DA
    Gertz, MA
    Inwards, DJ
    Lacy, MQ
    Tefferi, A
    Harmsen, WS
    Litzow, MR
    BONE MARROW TRANSPLANTATION, 2001, 27 (11) : 1133 - 1140
  • [22] The development of graft-versus-host disease prophylaxis
    Cutler, Corey
    HAEMATOLOGICA, 2023, 108 (03) : 657 - 658
  • [23] Graft-Versus-Host Disease (GVHD) after Post-Transplant Cyclophosphamide or Conventional GVHD Prophylaxis: Same Title, Different Song
    Solh, Melhem
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 623 - 624
  • [24] Early onset of acute graft-versus-host disease indicating a worse prognosis in terms of chronic graft-versus-host disease and survival compared to late onset
    Sohn, Sang Kyun
    Moon, Joon Ho
    Kim, Jong Gwang
    Chae, Yee Soo
    Cho, Yoon Young
    Ahn, Byung Min
    Kim, Shi Nae
    Lee, Soo Jung
    Kim, Yun Jeong
    BLOOD, 2007, 110 (11) : 322B - 322B
  • [25] Post-transplant graft-versus-host lymphadenopathy.
    Nodit, L
    Murase, N
    Reyes, JD
    Mazariegos, GV
    Sindhi, R
    Jaffe, R
    MODERN PATHOLOGY, 2004, 17 (02) : 270 - 270
  • [26] New advances in acute graft-versus-host disease prophylaxis
    Davies, JK
    Lowdell, MW
    TRANSFUSION MEDICINE, 2003, 13 (06) : 387 - 397
  • [27] Drug therapy for acute graft-versus-host disease prophylaxis
    Simpson, D
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 317 - 325
  • [28] Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
    Lazzari, Lorenzo
    Balaguer-Rosello, Aitana
    Montoro, Juan
    Greco, Raffaella
    Hernani, Rafael
    Lupo-Stanghellini, Maria Teresa
    Villalba, Marta
    Giglio, Fabio
    Facal, Ana
    Lorentino, Francesca
    Guerreiro, Manuel
    Bruno, Alessandro
    Perez, Ariadna
    Xue, Elisabetta
    Clerici, Daniela
    Piemontese, Simona
    Luis Pinana, Jose
    Angel Sanz, Miguel
    Solano, Carlos
    de la Rubia, Javier
    Ciceri, Fabio
    Peccatori, Jacopo
    Sanz, Jaime
    BONE MARROW TRANSPLANTATION, 2022, 57 (09) : 1389 - 1398
  • [29] Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
    Lorenzo Lazzari
    Aitana Balaguer-Roselló
    Juan Montoro
    Raffaella Greco
    Rafael Hernani
    Maria Teresa Lupo-Stanghellini
    Marta Villalba
    Fabio Giglio
    Ana Facal
    Francesca Lorentino
    Manuel Guerreiro
    Alessandro Bruno
    Ariadna Pérez
    Elisabetta Xue
    Daniela Clerici
    Simona Piemontese
    José Luis Piñana
    Miguel Ángel Sanz
    Carlos Solano
    Javier de la Rubia
    Fabio Ciceri
    Jacopo Peccatori
    Jaime Sanz
    Bone Marrow Transplantation, 2022, 57 : 1389 - 1398
  • [30] Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
    Im, Annie
    Rashidi, Armin
    Wang, Tao
    Hemmer, Michael
    MacMillan, Margaret L.
    Pidala, Joseph
    Jagasia, Madan
    Pavletic, Steven
    Majhail, Navneet S.
    Weisdorf, Daniel
    Abdel-Azim, Hisham
    Agrawal, Vaibhav
    Al-Homsi, A. Samer
    Aljurf, Mahmoud
    Askar, Medhat
    Auletta, Jeffery J.
    Bashey, Asad
    Beitinjaneh, Amer
    Bhatt, Vijaya Raj
    Byrne, Michael
    Cahn, Jean-Yves
    Cairo, Mitchell
    Castillo, Paul
    Cerny, Jan
    Chhabra, Saurabh
    Choe, Hannah
    Ciurea, Stefan
    Daly, Andrew
    Diaz Perez, Miguel Angel
    Farhadfar, Nosha
    Gadalla, Shahinaz M.
    Gale, Robert
    Ganguly, Siddhartha
    Gergis, Usama
    Hanna, Rabi
    Hematti, Peiman
    Herzig, Roger
    Hildebrandt, Gerhard C.
    Lad, Deepesh P.
    Lee, Catherine
    Lehmann, Leslie
    Lekakis, Lazaros
    Kamble, Rammurti T.
    Kharfan-Dabaja, Mohamed A.
    Khandelwal, Pooja
    Martino, Rodrigo
    Murthy, Hemant S.
    Nishihori, Taiga
    O'Brien, Tracey A.
    Olsson, Richard F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1459 - 1468
12345